During the past decade, Arizona Arthritis & Rheumatology Research PLLC conducted 64 clinical trials. In the 10-year time frame, 64 clinical trials started and 55 clinical trials were completed, i.e. on average, 85.9% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 40 clinical trials were completed. i.e. 160% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arizona Arthritis & Rheumatology Research PLLC" #1 sponsor was "Eli Lilly and Company" with 17 trials, followed by "Pfizer" with 15 trials sponsored, "Janssen Research & Development, LLC" with 8 trials sponsored, "Galapagos NV" with 4 trials sponsored and "Hoffmann-La Roche" with 4 trials sponsored. Other sponsors include 33 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arizona Arthritis & Rheumatology Research PLLC" #1 collaborator was "Incyte Corporation" with 5 trials as a collaborator, "OCT Clinical Trials" with 3 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator and "Quintiles, Inc." with 2 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Arizona Arthritis & Rheumatology Research PLLC" are "Rheumatoid Arthritis" (32 trials), "Arthritis, Psoriatic" (6 trials), "Psoriatic Arthritis" (6 trials), "Systemic Lupus Erythematosus" (6 trials) and "Arthritis, Rheumatoid" (5 trials). Many other conditions were trialed in "Arizona Arthritis & Rheumatology Research PLLC" in a lesser frequency.

Most popular intervention types in "Arizona Arthritis & Rheumatology Research PLLC" are "Drug" (76 trials), "Biological" (12 trials), "Other" (10 trials), "Device" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (41 trials), "Baricitinib" (8 trials), "Adalimumab" (7 trials), "Methotrexate" (7 trials) and "Ixekizumab" (6 trials). Other intervention names were less common.

The vast majority of trials in "Arizona Arthritis & Rheumatology Research PLLC" are 85 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Arizona Arthritis & Rheumatology Research PLLC". 1 are not yet recruiting, 13 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 56 completed trials in Arizona Arthritis & Rheumatology Research PLLC, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Arizona Arthritis & Rheumatology Research PLLC, 0 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 49 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 0 trials that are defined as “Not Applicable".

Arizona Arthritis & Rheumatology Research PLLC has several departments that took part in Clinical trials: "Arizona Arthritis and Rheumatology Research, PLLC" - 18 trials